3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide

C41H71N11O4 — CID 162453436

IUPAC3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide
SMILESCN1CCN([C@@H]2CCCN(C3CNC(C(N)=O)C(NC4CCC(C5CCN(CC6CCN(C7CCC([C@@H]8CCC(=O)NC8=O)CN7)CC6)CC5)CC4)N3)C2)C1=O
InChIInChI=1S/C41H71N11O4/c1-48-21-22-52(41(48)56)32-3-2-16-51(26-32)35-24-44-37(38(42)54)39(46-35)45-31-7-4-28(5-8-31)29-14-17-49(18-15-29)25-27-12-19-50(20-13-27)34-10-6-30(23-43-34)33-9-11-36(53)47-40(33)55/h27-35,37,39,43-46H,2-26H2,1H3,(H2,42,54)(H,47,53,55)/t28?,30?,31?,32-,33+,34?,35?,37?,39?/m1/s1
InChIKeyCNWLAQRTOAYTGH-SLFIBREISA-N
MW782.09 g/mol
LogP0.47
Rot. Bonds10

About 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide

3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide (PubChem CID 162453436) has the molecular formula C41H71N11O4 and a molecular weight of 782.09 g/mol. Its IUPAC name is 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide.

Molecular Properties

Compound Name3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide
PubChem CID162453436
Molecular FormulaC41H71N11O4
Molecular Weight782.09 g/mol
Exact Mass781.57
IUPAC Name3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide
SMILESCN1CCN([C@@H]2CCCN(C3CNC(C(N)=O)C(NC4CCC(C5CCN(CC6CCN(C7CCC([C@@H]8CCC(=O)NC8=O)CN7)CC6)CC5)CC4)N3)C2)C1=O
InChIInChI=1S/C41H71N11O4/c1-48-21-22-52(41(48)56)32-3-2-16-51(26-32)35-24-44-37(38(42)54)39(46-35)45-31-7-4-28(5-8-31)29-14-17-49(18-15-29)25-27-12-19-50(20-13-27)34-10-6-30(23-43-34)33-9-11-36(53)47-40(33)55/h27-35,37,39,43-46H,2-26H2,1H3,(H2,42,54)(H,47,53,55)/t28?,30?,31?,32-,33+,34?,35?,37?,39?/m1/s1
InChIKeyCNWLAQRTOAYTGH-SLFIBREISA-N
XLogP0.47
TPSA170.65 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500782.09
LogP ≤ 50.47
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide?
The IUPAC name of 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide (CID 162453436) is 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide.
What is the SMILES notation for 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide?
The canonical SMILES for 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide is CN1CCN([C@@H]2CCCN(C3CNC(C(N)=O)C(NC4CCC(C5CCN(CC6CCN(C7CCC([C@@H]8CCC(=O)NC8=O)CN7)CC6)CC5)CC4)N3)C2)C1=O.
What is the InChIKey of 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide?
The InChIKey is CNWLAQRTOAYTGH-SLFIBREISA-N. The full InChI is InChI=1S/C41H71N11O4/c1-48-21-22-52(41(48)56)32-3-2-16-51(26-32)35-24-44-37(38(42)54)39(46-35)45-31-7-4-28(5-8-31)29-14-17-49(18-15-29)25-27-12-19-50(20-13-27)34-10-6-30(23-43-34)33-9-11-36(53)47-40(33)55/h27-35,37,39,43-46H,2-26H2,1H3,(H2,42,54)(H,47,53,55)/t28?,30?,31?,32-,33+,34?,35?,37?,39?/m1/s1.
What are the key properties of 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide?
3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide has a molecular weight of 782.09 g/mol, XLogP of 0.47, 10 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[[4-[1-[[1-[5-[(3S)-2,6-dioxopiperidin-3-yl]piperidin-2-yl]piperidin-4-yl]methyl]piperidin-4-yl]cyclohexyl]amino]-5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]piperazine-2-carboxamide is sourced from PubChem (CID 162453436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).